The AMYPAD Consortium has already published several publications and is working on a range of further papers that are soon to be published in a variety of journals. During the last quarter, two AMYPAD papers have been published:
- “Quantitative amyloid PET in Alzheimer’s disease: the AMYPAD prognostic and natural history study”; This paper published in the Journal Alzheimer’s & Dementia describes the aim, study design and outcomes measures of the AMYPAD Prognostic Study.
- “Simulating the effect of cerebral blood flow changes on regional quantification of [18F]flutemetamol and [18F]florbetaben studies”; This study aimed to assess the effects of regional (i.e. target and reference tissues) and global cerebral blood flow (CBF) changes on quantitative amyloid measures derived from static, dynamic and dual-time window scanning protocols using reference tissue approaches, thereby focusing on [18F]flutemetamol and [18F]florbetaben, the two tracers used within the AMYPAD consortium. Findings were published in the Journal of Cerebral Blood Flow & Metabolism.
AMYPAD has a page in the networking platform Research Gate in order to be used as an online repository for all AMYPAD publications. Click on this link to find those already available and let’s connect to make Research Gate a great place to find our papers, ask questions and find collaborators.
We are also pleased that Lyduine Collij, PhD student at the VU University Medical Center Amsterdam (VUmc, Netherlands), has been awarded the Alavi-Mandell Award for her publication entitled “Assessing Amyloid Pathology in Cognitively Normal Subjects using [18F]Flutemetamol PET: Comparing Visual Reads and Quantitative Methods”. This manuscript was conducted within the AMYPAD project and published online in October 2018. The Alavi-Mandell Award is given to individuals who are the first author of excellent papers published in the Journal of Nuclear Medicine and who provide added value to the field. Congratulations Lyduine! Well-deserved!
